Compounds such as sulforaphane and dimethyl fumarate, both potent Nrf2 activators, have shown considerable promise in clinical trials for reducing oxidative stress and inflammation—key factors in neurodegenerative diseases. The gene discussed is NFE2L2; the disease is neurodegenerative disease.